The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Aprea Therapeutics Appoints Nadeem Q. Mirza, M.D., M.P.H. As Chief Medical Officer
PUBLIC · APREMay 02, 2024•about 2 years ago
Company
Aprea Therapeutics
DoylestownBiotechnologyHealth CareScience And EngineeringTherapeutics
Description
Aprea Therapeutics, Inc. has appointed Nadeem Q. Mirza as the Chief Medical Officer, effective May 1, 2024
Company Information
Company
Aprea Therapeutics
Location
Doylestown, Pennsylvania, United States
About
Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. We exist to ensure that cancer doesn't interrupt life's possibilities and dreams. We do this through our unique approach to synthetic lethality that is revolutionizing the future of cancer treatment.
DoylestownBiotechnologyHealth CareScience And EngineeringTherapeutics